Radiation Therapy for Breast Cancer

Hematology/Oncology Clinics of North America

Volumn 20, Issue 2, 2006, Pages 239-257

  Bellon, Jennifer R ^a   Katz, Angela ^b   Taghian, Alphonse ^b  

^a DANA FARBER CANCER INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUOROURACIL; METHOTREXATE; PACLITAXEL; TAMOXIFEN;

BRACHYTHERAPY; BREAST CANCER; CANCER SURVIVAL; CLINICAL TRIAL; HUMAN; IRRADIATION; MASTECTOMY; META ANALYSIS; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; SYSTEMIC THERAPY;

BREAST NEOPLASMS; COMBINED MODALITY THERAPY; DOSE FRACTIONATION; FEMALE; HUMANS; MASTECTOMY; SURVIVAL ANALYSIS; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 33646805760     PISSN: 08898588     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hoc.2006.01.014     Document Type: Review

References (94)

1. Early Breast Cancer Trialists Collaborative Group. Favourable and unfavourable effects on long-term survival of radiotherapy for early breast cancer: an overview of the randomised trials. Lancet 355 (2000) 1757-1770
2. Overgaard M., Hansen P.S., Overgaard J., et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. N Engl J Med 337 (1997) 949-955
3. Pierce L.J., Griffith K.A., Hayman J.A., et al. Conservative surgery and radiotherapy for stage I/II breast cancer using lung density correction: 10-year and 15-year results. Int J Radiat Oncol Biol Phys 61 (2005) 1317-1327
4. Pierce L., Oberman H., Strawderman M., et al. Microscopic extracapsular extension in the axilla: is this an indication for axillary radiotherapy?. Int J Radiat Oncol Biol Phys 33 (1995) 253-259
5. Taghian A., Assaad S., Niemierko A., et al. Risk of pneumonitis in breast cancer patients treated with radiation therapy and combination chemotherapy with paclitaxel. J Natl Cancer Inst 23 (2001) 1806-1811
6. Shapiro C., and Recht A. Late effects of adjuvant therapy for breast cancer. J Natl Cancer Inst Monogr 16 (1994) 101-112
7. Host H., Brenhovd I.O., and Loeb M. Postoperative radiotherapy in breast cancer: long-term results from the Oslo study. Int J Radiat Oncol Biol Phys 12 (1986) 727-732
8. Olson J., Neuberg D., and Pandya K.J. The role of radiotherapy in the management of operable locally advanced breast carcinoma: result of a trial by the Eastern Cooperative Oncology Group. Cancer 79 (1997) 1138-1149
9. Rutqvist L., Petterson D., and Johansson H. Adjuvant radiation therapy versus surgery alone in operable breast cancer: long-term follow-up of a randomized clinical trial. Radiother Oncol 26 (1993) 104-110
10. Cuzick J., Stewart H., Peto R., et al. Overview of randomized trials of postoperative adjuvant radiotherapy in breast cancer. Cancer Treat Rep 71 (1987) 15-29
11. Cuzick J., Stewart H., Rutqvist L., et al. Cause-specific mortality in long-term survivors of breast cancer who participated in trials of radiotherapy. J Clin Oncol 12 (1994) 447-453
12. Early Breast Cancer Trialists Collaborative Group. Effects of radiotherapy and surgery in early breast cancer: an overview of the randomized trials. N Engl J Med 333 (1995) 1444-1455
13. Fowble B., Gray R., Gilchrist K., et al. Identification of a subgroup of patients with breast cancer and histologically positive axillary nodes receiving chemotherapy who may benefit from postoperative radiotherapy. J Clin Oncol 6 (1988) 1107-1117
14. Suit H.D.W.S. Impact of improved local control on survival. Int J Radiat Oncol Biol Phys 12 (1986) 453-458
15. Ragaz J., Jackson S.M., Le N., et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 337 (1997) 956-962
16. Overgaard M., Jensen M.B., Overgaard J., et al. Postoperative radiotherapy in high-risk postmenopausal breast cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomized trial. Lancet 353 (1999) 1641-1648
17. Katz A., Strom E., Buchholz T.H., et al. Locoregional recurrence patterns after mastectomy and doxorubicin-based chemotherapy: implications for postoperative irradiation. J Clin Oncol 18 (2000) 2817-2827
18. Recht A., Gray R., Davidson N., et al. Locoregional failure 10 years after mastectomy and adjuvant chemotherapy with or without tamoxifen without irradiation: experience of the Eastern Cooperative Oncology Group. J Clin Oncol 17 (1999) 1689-1700
19. Taghian A., Jeong J.-H., Mamounas E., et al. Patterns of locoregional failure in patients with operable breast cancer treated by mastectomy and adjuvant chemotherapy with or without tamoxifen and without radiotherapy: results from five National Surgical Adjuvant Breast and Bowel Project randomized clinical trials. J Clin Oncol 22 21 (2004) 4247-4254
20. Ceilley E., Jagsi R., Goldberg S., et al. Radiotherapy for invasive breast cancer in North America and Europe: results of a survey. Int J Radiat Oncol Biol Phys 61 2 (2005) 365-373
21. Kunkler I., Price A., Dixon M., et al. SUPREMO (selective use of postoperative radiotherapy after mastectomy): a phase III randomised trial assessing the role of postmastectomy chestwall irradiation in "intermediate risk" women with operable breast cancer receiving adjuvant systemic therapy. Presented at the 12th International Congress of Radiation Research. Brisbane (Queensland, Australia), August 17-22, 2003
22. Sartor C.I., Peterson B.L., Woolf S., et al. Effect of addition of adjuvant paclitaxel on radiotherapy delivery and locoregional control of node-positive breast cancer: Cancer and Leukemia Group B 9344. J Clin Oncol 23 1 (2005) 30-40
23. Fisher B., Anderson S., Bryant J., et al. Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer. N Engl J Med 347 16 (2002) 1233-1241
24. Arriagada R., Rutqvist L.E., Mattsson A., et al. Adequate locoregional treatment for early breast cancer may prevent secondary dissemination. J Clin Oncol 13 (1995) 2869-2878
25. Poggi M., Danforth D., Sciuto L., et al. Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy. Cancer 98 (2003) 697-702
26. Veronesi U., Cascinelli N., Mariani L., et al. Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer. N Engl J Med 347 16 (2002) 1227-1232
27. Blichert-Toft M., Rose C., Anderson J.A., et al. Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life table analysis. J Natl Cancer Inst Monogr 11 (1992) 19-26
28. van Dongen J., Voogd A.C., Fentiman I.S., et al. Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European Organization for Research and Treatment of Cancer 10801 trial. J Natl Cancer Inst 92 (2000) 1143-1150
29. Clark R., Whelan T., Levine M., et al. Randomized clinical trial of breast irradiation following lumpectomy and axillary dissection for node-negative breast cancer: an update. J Natl Cancer Inst 88 (1996) 1659-1664
30. Liljegren G., Homberg L., Bergh J., et al. 10-Year results after sector resection with or without postoperative radiotherapy for stage I breast cancer: a randomized trial. J Clin Oncol 17 (1999) 2326-2333
31. Holli K., Saaristo R., Isola J., et al. Lumpectomy with or without postoperative radiotherapy for breast cancer with favourable prognostic features: results of a randomized study. Br J Cancer 84 (2001) 164-169
32. Whelan T., Julian J., Wright J., et al. Does locoregional radiation therapy improve survival in breast cancer? A meta-analysis. J Clin Oncol 18 (2000) 1220-1229
33. Vicini F.A., Kestin L., and Huang R. Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy?. Cancer 97 (2003) 910-919
34. Vinh-Hung V., and Verschraegen C. Breast-conserving surgery with or without radiotherapy: pooled-analysis for risks of ipsilateral breast tumor recurrence and mortality. J Natl Cancer Inst 96 (2004) 115-121
35. Early Breast Cancer Trialists Collaborative Group. Effect of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and on 15-year survival: an overview of the randomized trials. Lancet 366 (2005) 2087-2106
36. Hughes K., Schnaper L.A., Berry D., et al. Lumpectomy plus tamoxifen with or without irradiation in women 70 years of age or older with early breast cancer. N Engl J Med 351 10 (2004) 971-977
37. Fyles A.W., McCready D.R., Manchul L.A., et al. Tamoxifen with or without breast irradiation in women 50 years of age or older with early breast cancer. N Engl J Med 351 10 (2004) 963-970
38. Fisher B., Bryant J., Dignam J.J., et al., for the National Surgical Adjuvant Breast and Bowel Project. Tamoxifen, radiation therapy, or both for prevention of ipsilateral breast tumor recurrence after lumpectomy in women with invasive breast cancers of one centimeter or less. J Clin Oncol 20 (2002) 1-9
39. Whelan T., MacKenzie R., Julian J., et al. Randomized trial of breast irradiation schedules after lumpectomy for women with lymph node-negative breast cancer. J Natl Cancer Inst 94 (2002) 1143-1150
40. Ortholan C., Hannoun-Levi L.J., Ferrero J.M., et al. Long-term results of adjuvant hypofractionated radiotherapy for breast cancer in elderly patients. Int J Radiat Oncol Biol Phys 61 (2005) 154-162
41. Arthur D.W., and Vicini F.A. Accelerated partial breast irradiation as a part of breast conservation therapy. J Clin Oncol 23 8 (2005) 1726-1735
42. Schnitt S., Hayman J., Gelman R., et al. A prospective study of conservative surgery alone in the treatment of selected patients with stage I breast cancer. Cancer 77 (1996) 1094-1100
43. Buchholz T.A., Tucker S.L., Erwin J., et al. Impact of systemic treatment on local control for patients with lymph node-negative breast cancer treated with breast-conservation therapy. J Clin Oncol 19 (2001) 2240-2246
44. Fisher B., Dignam J., Mamounas E., et al. Sequential methotrexate and fluorouracil for the treatment of node- negative breast cancer patients with estrogen receptor-negative tumors: eight-year results from the NSABP B-13 and first report of findings from NSABP B-19 comparing methotrexate and fluorouracil with conventional cyclophosphamide, methotrexate, and fluorouracil. J Clin Oncol 14 (1996) 1982-1992
45. Thomas P.R., and Lindblad A.S. Adjuvant postoperative radiotherapy and chemotherapy in rectal carcinoma: a review of the Gastrointestinal Tumor Study Group experience. Radiother Oncol 13 (1988) 245-252
46. Penland S.K., and Socinski M.A. Management of unresectable stage III non-small cell lung cancer: the role of combined chemoradiation. Semin Radiat Oncol 14 (2004) 326-334
47. Huncharek M., and McGarry R. A meta-analysis of the timing of chest irradiation in the combined modality treatment of limited-stage small cell lung cancer. Oncologist 9 (2004) 665-672
48. Green J.A., Kirwan J.M., Tierney J.F., et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 358 (2001) 781-786
49. Assersohn L., Powles T.J., Ashley S., et al. Local relapse in primary breast cancer patients with unexcised positive surgical margins after lumpectomy, radiotherapy and chemoendocrine therapy. Ann Oncol 10 (1999) 1451-1455
50. Markiewicz D.A., Fox K.R., Schultz D.J., et al. Concurrent chemotherapy and radiation for breast conservation treatment of early-stage breast cancer. Cancer J Sci Am 4 (1998) 185-193
51. Bellon J.R., Shulman L.N., Come S.E., et al. A prospective study of concurrent cyclophosphamide/methotrexate/5-fluorouracil and reduced-dose radiotherapy in patients with early-stage breast carcinoma. Cancer 100 (2004) 1358-1364
52. Bellon J., Lindsley K., Ellis G., et al. Concurrent radiation therapy and paclitaxel or docetaxel chemotherapy in high-risk breast cancer. Int J Radiat Oncol Biol Phys 48 (2000) 393-397
53. Ellerbroek N., Martino S., Mautner B., et al. Breast-conserving therapy with adjuvant paclitaxel and radiation therapy: feasibility of concurrent treatment. Breast J 9 (2003) 74-78
54. Hanna Y., Baglan K.L., Stromberg J.S., et al. Acute and subacute toxicity associated with concurrent adjuvant radiation therapy and paclitaxel in primary breast cancer therapy. Breast J 8 (2002) 149-153
55. Burstein H., Bellon J., Galper S., et al. Prospective evaluation of concurrent paclitaxel and radiation therapy following adjuvant doxorubicin and cyclophosphamide chemotherapy for stage II or III breast cancer. Int J Radiat Oncol Biol Phys 64 2 (2006) 496-504
56. Hartsell W., Recine D., Griem K., et al. Delaying the initiation of intact breast irradiation for patients with lymph node positive breast cancer increases the risk of local recurrence. Cancer 76 (1995) 2497-2503
57. Buchholz T.A., Austin-Seymour M.M., Moe R.E., et al. Effect of delay in radiation in the combined modality treatment of breast cancer. Int J Radiat Oncol Biol Phys 26 (1993) 23-25
58. Recht A., Come S., Gelman R.S., et al. Integration of conservative surgery, radiotherapy, and chemotherapy for the treatment of early-stage, node-positive breast cancer: sequencing, timing, and outcome. J Clin Oncol 9 (1991) 1662-1667
59. Vujovic O., Perera F., Dar A.R., et al. Does delay in breast irradiation following conservative breast surgery in node-negative breast cancer patients have an impact on risk of recurrence?. Int J Radiat Oncol Biol Phys 40 (1991) 869-874
60. Leonard C.E., Wood M.E., Zhen B., et al. Does administration of chemotherapy before radiotherapy in breast cancer patients treated with conservative surgery negatively impact local control?. J Clin Oncol 13 (1995) 2906-2915
61. Buchholz T.A., Hunt K., Amosson C.M., et al. Sequencing of chemotherapy and radiation in lymph node-negative breast cancer. Cancer J Sci Am 5 (1999) 159-164
62. Recht A., Come S., Henderson I., et al. The sequencing of chemotherapy and radiation therapy after conservative surgery for early-stage breast cancer. N Engl J Med 334 (1996) 1356-1361
63. Bellon J.R., Come S.E., Gelman R.S., et al. Sequencing of chemotherapy and radiation therapy in early-stage breast cancer: updated results of a prospective randomized trial. J Clin Oncol 23 9 (2005) 1934-1940
64. Osborne C., Boldt D., Clark G., et al. Effects of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer. Cancer Res 43 (1983) 3583-3585
65. Albain K., Green J., Ravdin P., et al. Adjuvant chemo-hormonal therapy for primary breast cancer should be sequential instead of concurrent: initial results from Intergroup trial 0100 [abstract 143]. Proc Am Soc Clin Oncol 21 (2002) 37a
66. Ahn P.H., Vu H.T., Lannin D., et al. Sequence of radiotherapy with tamoxifen in conservatively managed breast cancer does not affect local relapse rates. J Clin Oncol 23 (2005) 17-23
67. Harris E.E.R., Christensen V.J., Hwang W.-T., et al. Impact of concurrent versus sequential tamoxifen with radiation therapy in early-stage breast cancer patients undergoing breast conservation treatment. J Clin Oncol 23 (2005) 11-16
68. Pierce L.J., Hutchins L.F., Green S.R., et al. Sequencing of tamoxifen and radiotherapy after breast-conserving surgery in early-stage breast cancer. J Clin Oncol 2005 (2004) 24-29
69. Smith T.E., Lee D., Turner B.C., et al. True recurrence vs. new primary ipsilateral breast tumor relapse: an analysis of clinical and pathologic differences and their implications in natural history, prognoses, and therapeutic management. Int J Radiat Oncol Biol Phys 48 5 (2000) 1281-1289
70. Recht A., Come S.E., Troyan S., et al. Local-regional recurrence after mastectomy or breast-conserving therapy. In: Harris Jr. L.M., Morrow M., et al. (Eds). Diseases of the breast. 2nd edition (2000), Lippincott Williams & Wilkins, Philadelphia 731-748
71. Vicini F.A., Goldstein N.S., Pass H., et al. Use of pathologic factors to assist in establishing adequacy of excision before radiotherapy in patients treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 60 (2004) 86-94
72. Mazeron J., Simon J.M., Crook J., et al. Influence of dose rate on local control of breast carcinoma treated by external beam irradiation plus iridium 192 implant. Int J Radiat Oncol Biol Phys 21 (1991) 1173-1177
73. Lawenda B.D., Taghian A.G., Kachnic L.A., et al. Dose-volume analysis of radiotherapy for T1N0 invasive breast cancer treated by local excision and partial breast irradiation by low-dose-rate interstitial implant. Int J Radiat Oncol Biol Phys 56 (2003) 671-680
74. Vicini F.A., Baglan K.L., Kestin L.L., et al. Accelerated treatment of breast cancer. J Clin Oncol 19 7 (2001) 1993-2001
75. Wazer D.E., Berle L., Graham R., et al. Preliminary results of a phase I/II study of HDR brachytherapy alone for T1/T2 breast cancer. Int J Radiat Oncol Biol Phys 53 4 (2002) 889-897
76. Polgar C., Sulyok Z., Fodor J., et al. Sole brachytherapy of the tumor bed after conservative surgery for T1 breast cancer: five-year results of a phase I-II study and initial findings of a randomized phase III trial. J Surg Oncol 80 (2002) 121-129
77. Perera F., Engel J., Holliday R., et al. Local resection and brachytherapy confined to the lumpectomy site for early breast cancer: a pilot study. J Surg Oncol 65 (1997) 263-268
78. Wazer D., Lowther D., Boyle T., et al. Clinically evident fat necrosis in women treated with high-dose-rate brachytherapy alone for early-stage breast cancer. Int J Radiat Oncol Biol Phys 50 (2001) 107-111
79. Keisch M., Vicini F., Kuske R.R., et al. Initial clinical experience with the MammoSite breast brachytherapy applicator in women with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 55 (2003) 289-293
80. Keisch M., Vicini F., Kuske R., et al. Two-year outcome with the MammoSite breast brachytherapy applicator: factors associated with optimal cosmetic results when performing partial breast irradiation. Int J Radiat Oncol Biol Phys 57 2, Suppl 1 (2003) S315
81. Shah N., Tenenholz T., Arthur D., et al. MammoSite and interstitial brachytherapy for accelerated partial breast irradiation: factors that affect toxicity and cosmesis. Cancer 101 4 (2004) 727-734
82. Richards G., Berson A., Rescigno J., et al. Acute toxicity of high-dose-rate intracavitary brachytherapy with the MammoSite applicator in patients with early-stage breast cancer. Ann Surg Oncol 11 8 (2004) 739-746
83. Dowlatshahi K., Gittleman M.A., Nguyen C., et al. Early experience with balloon brachytherapy for breast cancer. Arch Surg 139 (2004) 603-607
84. Zannis V.J., Walker L.C., Barclay-White B., et al. Postoperative ultrasound-guided percutaneous placement of a new breast brachytherapy balloon catheter. Am J Surg 186 4 (2003) 383-385
85. Harper J.L., Jenrette J.M., Vanek K.N., et al. Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience. Int J Radiat Oncol Biol Phys 61 1 (2005) 169-174
86. Shah N.M., and Wazer D.E. The MammoSite balloon brachytherapy catheter for accelerated partial breast irradiation. Semin Radiat Oncol 15 (2005) 100-107
87. Vaidya J.S., Tobias J.S., Baum M., et al. TARGeted Intraoperative radiotherapy (TARGIT): an innovative approach to partial-breast irradiation. Semin Radiat Oncol 15 (2005) 84-91
88. Tobias J.S., Vaidya J.S., Keshtgar M., et al. Reducing radiotherapy dose in early breast cancer: the concept of conformal intraoperative brachytherapy. Br J Radiol 77 916 (2004) 279-284
89. Veronesi U., Gatti G., Luini A., et al. Full-dose intraoperative radiotherapy with electrons during breast-conserving surgery. Arch Surg 138 (2003) 1253-1256
90. Vicini F., Remouchamps V., Wallace M., et al. Ongoing clinical experience utilizing 3D conformal external beam radiotherapy to deliver partial-breast irradiation in patients with early-stage breast cancer treated with breast-conserving therapy. Int J Radiat Oncol Biol Phys 57 5 (2003) 1247-1253
91. Formenti S.C., Truong M.T., Goldberg J.D., et al. Prone accelerated partial breast irradiation after breast-conserving surgery: preliminary clinical results and dose-volume histogram analysis. Int J Radiat Oncol Biol Phys 60 2 (2004) 493-504
92. Taghian A., Kozak K.R., Doppke K.P., et al. Initial dosimetric experience using simple three-dimensional conformal external-beam accelerated partial breast irradiation. Int J Radiat Oncol Biol Phys Jan 4 (2006) [Epub ahead of print]
93. Powell S.N., Doppke K.P., Chen G.T., et al. Set-up uncertainty in accelerated partial-breast irradiation using 3D-conformal external beam radiotherapy: a companion study to a prospective phase I ongoing trial. Int J Radiat Oncol Biol Phys 60 Suppl 1 (2004) S400-S401
94. National Surgical Adjuvant, Breast, and Bowel Project (NSABP B-39/RTOG 0413). A randomized phase III study of conventional whole breast irradiation (WBI) versus partial breast irradiation (PBI) for women with stage 0, I, or II breast cancer. Vol. 2005. Available at:. http://www.nsabp.pitt.edu/B-39.htm Accessed March 1, 2006